Democratic Republic of the Congo

Status: affected by circulating vaccine-derived poliovirus

The Democratic Republic of the Congo has not reported a case of wild poliovirus since 2011, however, the country is affected by circulating vaccine derived poliovirus. To stop transmission, it is essential for momentum to be maintained to reach every child with polio vaccines and to strengthen disease surveillance.

Polio this week in Central Africa

  • No new cases of type 2 circulating vaccine-derived poliovirus (cVDPV2) were reported this week in the Democratic Republic of the Congo (DR Congo).
  • The total number of cVDPV2 cases this year is nine, in two separate outbreaks: in Haut Lomami province (seven cases, with onset of paralysis of the most recent case on 27 July); and in Maniema province (two cases with onset of paralysis on 26 March and 18 April, with an additional isolate detected in a healthy individual with sample collection on 2 May).
  • Outbreak response continues to take place, including use of monovalent oral polio vaccine type 2 (mOPV2) in line with internationally-agreed outbreak response protocols.
  • The next immunisation activities are scheduled for the end of October, using bOPV vaccine to immunise over 10 million children.
  • Surveillance and immunization activities are being strengthened in neighbouring countries

International Health Regulations

The Democratic Republic of the Congo is classified by the International Health Regulations (IHR) as a state infected with cVDPV2, with potential risk of international spread.  It is therefore subject to temporary recommendations as of August 2017.

loading map...
Key at-risk: no longer poliovirus-infected, but at high risk of outbreaks
Outbreak: has stopped indigenous WPV circulation but affected by outbreak of imported WPV or circulating vaccine-derived poliovirus
Endemic: has never stopped indigenous wild poliovirus (WPV) circulation

Travel advice

WHO’s International Travel and Health recommends that all travellers to polio-affected areas be fully vaccinated against polio. Residents (and visitors for more than 4 weeks) from infected areas should receive an additional dose of OPV or inactivated polio vaccine (IPV) within 4 weeks to 12 months of travel.

More on vaccine-derived polioviruses